Available as aerosol, gel, dental patch, lozenge, ointment, paste, solution
An ester local anesthetic
Hurricaine®, Zilactin®, Anbesol®, Orabase®, Orajel®, Children's Chloraseptic®
Many different forms and concentrations
Must be individualized for each patient
Duration 10-20 minutes
-Oraqix should not be used in those patients with congenital or idiopathic methemoglobinemia and in infants under the age of twelve months who are receiving treatment with methemoglobin-inducing agents.
-Signs and symptoms of methemoglobinemia may be delayed some hours after exposure. Initial signs and symptoms of the methemoglobinemia are characterized by a slate grey cyanosis seen in, e.g., buccal mucous membranes, lips and nail beds. In severe cases symptoms may include central
-Patients taking drugs associated with drug-induced methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbitol, phenytoin, primaquine, and quinine are at greater risk for developing methemoglobinemia.
-Treatment with Oraqix should be avoided in patients with any of the above conditions or with a previous history of problems in connection with prilocaine treatment